PLK1 blockade reportedly could lower the expression of Myc in tumor cells, since Myc inactivation has been demonstrated to induce the down-regulation of PDL1, an immunosuppressive molecule 39-42, which was identified as the major trigger of T cell exhaustion. Here, PLK1 is linked to neoplasm.